Exelixis
EXEL
#1636
Rank
C$18.68 B
Marketcap
C$74.32
Share price
-0.69%
Change (1 day)
31.56%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Earnings for Exelixis (EXEL)

Earnings in 2026 (TTM): C$1.38 Billion

According to Exelixis's latest financial reports the company's current earnings are C$2.37 Billion. In 2025 the company made an earning of C$1.31 Billion, an increase over its 2024 earnings that were of C$0.95 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Exelixis from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) C$1.38 B5.05%
2025 C$1.31 B38.08%
2024 C$0.95 B164.69%
2023 C$0.36 B9.89%
2022 C$0.32 B-20.33%
2021 C$0.41 B124.82%
2020 C$0.18 B-67.14%
2019 C$0.55 B-11.94%
2018 C$0.63 B185.09%
2017 C$0.22 B-325.82%
2016 -C$98.24 Million-58.12%
2015 -C$0.24 Billion-37.61%
2014 -C$0.38 Billion9.75%
2013 -C$0.35 Billion65.96%
2012 -C$0.21 Billion-291.63%
2011 C$0.10 B-195.59%
2010 -C$0.12 Billion-42.17%
2009 -C$0.2 Billion-18.98%
2008 -C$0.25 Billion-6.99%
2007 -C$0.26 Billion46.3%
2006 -C$0.18 Billion33.25%
2005 -C$0.14 Billion-30.92%
2004 -C$0.2 Billion44.29%
2003 -C$0.14 Billion12.86%
2002 -C$0.12 Billion22.79%
2001 -C$96.03 Million60.14%
2000 -C$59.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$36.34 B 2,489.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$14.81 B 955.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.71 B 805.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$10.71 B 663.41%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
C$18.39 B 1,211.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$13.42 B 856.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$14.00 B 897.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
-C$45.55 Million-103.25%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-C$40.63 Million-102.89%๐Ÿ‡บ๐Ÿ‡ธ USA